Benjamin Rovinski
Directeur/Membre du Conseil chez Life Sciences Ontario
Profil
Benjamin Rovinski is currently a Director at Iterion Therapeutics, Inc., Antiva Biosciences, Inc., Lumira Capital Investment Management, Inc., Ontario Genomics Institute (Private Equity), Life Sciences Ontario, Antios Therapeutics, Inc., and Bright Angel Therapeutics, Inc. He previously held Director positions at Inovise Medical, Inc., Signature BioScience, Inc., Morphotek, Inc., KAI Pharmaceuticals, Inc., SGX Pharmaceuticals, Inc., Health Hero Network, Inc., Avalon Pharmaceuticals, Inc., Protana, Inc., Sanofi Pasteur Ltd., Cervelo Pharmaceuticals Ltd., Vascular Pharmaceuticals, Inc., and G1 Therapeutics, Inc. He was also an Independent Director at Aurinia Pharmaceuticals, Inc. from 2013 to 2019.
Rovinski received his undergraduate degree from Rice University and his doctorate from McGill University.
Postes actifs de Benjamin Rovinski
| Sociétés | Poste | Début |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Private Equity Investor | - |
| Life Sciences Ontario | Directeur/Membre du Conseil | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - |
Bright Angel Therapeutics, Inc.
 Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | - |
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Directeur/Membre du Conseil | - |
Iterion Therapeutics, Inc.
 Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de Benjamin Rovinski
| Sociétés | Poste | Fin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 26/06/2019 |
Cervelo Pharmaceuticals Ltd.
 Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Directeur/Membre du Conseil | 15/12/2009 |
| ░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Benjamin Rovinski
| Rice University | Undergraduate Degree |
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 18 |
|---|---|
Inovise Medical, Inc.
 Inovise Medical, Inc. Medical SpecialtiesHealth Technology Inovise Medical, Inc. develops, produces and distributes cardiology products. The firms products includes Audicor AM monitor, Audicor sensor 4.0 and Audicor TS data sheet. The company was founded in by Patricia White in March 1997 and is headquartered in Beaverton, OR. | Health Technology |
Signature BioScience, Inc.
 Signature BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Signature BioScience, Inc. discovers new drugs by applying its parallel target and compound selection process. The private company is based in Hayward, CA and has subsidiaries in the United States. The company was founded by Andrew Peter Sandham and John Hefti. | Commercial Services |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Iterion Therapeutics, Inc.
Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Health Hero Network, Inc.
 Health Hero Network, Inc. Information Technology ServicesTechnology Services Robert Bosch Healthcare Systems, Inc. was engaged in the design, development, and distribution of patient monitoring systems. The firm offered health management programs delivering personalized daily monitoring and patient education. The company was founded in 1988 and was headquartered in Palo Alto, CA. | Technology Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Protana, Inc.
 Protana, Inc. Miscellaneous Commercial ServicesCommercial Services Protana, Inc. provides pharmaceutical and biotechnology research services. It provides protein identification, protein interaction mapping, differential analysis, biomarker discovery, chemical proteomics, and insilico drug design services. The company provides services to medical and biopharmaceutical companies. The company headquartered in Toronto, Canada. | Commercial Services |
Sanofi Pasteur Ltd.
 Sanofi Pasteur Ltd. BiotechnologyHealth Technology Sanofi Pasteur Ltd. develops, manufactures, and markets vaccines and immunotherapeutic products. It offers vaccines for haemophilus influenza type B (Hib), diphtheria, pertussis, poliomyelitis, tetanus, hepatitis A, influenza, poliomyelitis, rabies, meningococcal disease, typhoid fever, and yellow fever, as well as oncology products for bladder cancers. The company was founded John Gerald FitzGerald in 1914 and is headquartered in Toronto, Canada. | Health Technology |
Cervelo Pharmaceuticals Ltd.
Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Health Technology |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
| Life Sciences Ontario | |
Vascular Pharmaceuticals, Inc.
 Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
Bright Angel Therapeutics, Inc.
Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Health Technology |
